FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ken Herrmann

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Akram Al-Ibraheem; Ambros J Beer; Matthias R Benz; Andreas K Buck; Bernhard Haller; Hendrik Juenger; Asem Mansour; Kelsey L Pomykala; Maximilian Rudert; Klemens Scheidhauer; Markus Schwaiger; Ken Herrmann
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Nicolas Graf; Ken Herrmann; Ulrich Keller; Barbara Numberger; Christian Peschel; Tibor Schuster; Markus Schwaiger; Reingard Senekowitsch-Schmidtke; Hans-Jürgen Wester; Daniela Zwisler; Michaela Aichler; Tobias Dechow; Annette Feuchtinger; Andreas K Buck
[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner.
Zhoulei Li; Christian Peschel; Markus Schwaiger; Axel Walch; Michaela Aichler; Anja Baumgart; Andreas Buck; Annette Feuchtinger; Nicolas Graf; Ken Herrmann; Alexandra Jünger; Ulrich Keller; Tobias Dechow
FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ken Herrmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Akram Al-Ibraheem; Ambros J Beer; Matthias R Benz; Andreas K Buck; Bernhard Haller; Hendrik Juenger; Asem Mansour; Kelsey L Pomykala; Maximilian Rudert; Klemens Scheidhauer; Markus Schwaiger; Ken Herrmann
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Cancer 2013;119(6):1227-34.
2013: Nicolas Graf; Ken Herrmann; Ulrich Keller; Barbara Numberger; Christian Peschel; Tibor Schuster; Markus Schwaiger; Reingard Senekowitsch-Schmidtke; Hans-Jürgen Wester; Daniela Zwisler; Michaela Aichler; Tobias Dechow; Annette Feuchtinger; Andreas K Buck
[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner.
European journal of nuclear medicine and molecular imaging 2013;40(1):34-43.
2012: Zhoulei Li; Christian Peschel; Markus Schwaiger; Axel Walch; Michaela Aichler; Anja Baumgart; Andreas Buck; Annette Feuchtinger; Nicolas Graf; Ken Herrmann; Alexandra Jünger; Ulrich Keller; Tobias Dechow
FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy.
Cancer research 2012;72(19):5014-24.
2012: Ivonne Regel; Christoph Röcken; Roland Schmid; Wolfgang Zimmermann; Henrik Einwächter; Teresa Friedrich; Ken Herrmann; Ralf Hofheinz; Rupert Langer; Lisa Merkl; Elke Burgermeister; Matthias P A Ebert
Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2.
Gastroenterology 2012;143(1):99-109.e10.
2012: Ken Herrmann; J Kleeff; R M Schmid; T Schuster; Markus Schwaiger; Jens T Siveke; Hans-Jürgen Wester; Ambros J Beer; Martin Dobritz; M Erkan; H Friess; Andreas K Buck
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.
European journal of nuclear medicine and molecular imaging 2012;39(5):846-51.
2012: Tobias Maurer; Katharina Opercan; Stefan Schmidt; Markus Schwaiger; Michael Souvatzoglou; Jens Stollfuss; Juergen E Gschwend; Bernhard Haller; Ken Herrmann; Bernd J Krause; Hubert Kübler; Gregor Weirich; Uwe Treiber
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
European urology 2012;61(5):1031-8.
2011: Ken Herrmann; Andreas K Buck; Tobias Dechow; Nicolas Graf; Christian Peschel; Martina Rudelius; Christine Scheuerer; Tibor Schuster; Markus Schwaiger; Hans-Jürgen Wester; Ulrich Keller
A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(12):1898-902.
2011: Ken Herrmann; Karen Becker; Ralph A Bundschuh; Markus Essler; Helmut Friess; Christine Praus; Robert Rosenberg; Stefan Schmidt; Tibor Schuster; Markus Schwaiger; Michael Souvatzoglou; Hinrich A Wieder; Sibylle I Ziegler; Bernd J Krause
Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011;13(5):1011-9.
2011: Christian Meyer zum Büschenfelde; Karin Becker; Matthias Ebert; Helmut Friess; Hans Geinitz; Ken Herrmann; Rupert Langer; Florian Lordick; Katja Ott; Christian Peschel; Tibor Schuster; Markus Schwaiger; Frank Zimmermann; Bernd Joachim Krause
(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1189-96.
2011: Michael Souvatzoglou; Gregor Weirich; Sarah Schwarzenboeck; Tobias Maurer; Tibor Schuster; Ralph Alexander Bundschuh; Matthias Eiber; Ken Herrmann; Hubert Kuebler; Hans-Jürgen Wester; Heinz Hoefler; Juergen E Gschwend; Markus Schwaiger; Uwe Treiber; Bernd J Krause
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(11):3751-9.
2011: Ken Herrmann; Andreas K Buck; Tibor Schuster; Alexandra Junger; Nicolas Graf; Ingo Ringshausen; Martina Rudelius; Hans-Jürgen Wester; Markus Schwaiger; Ulrich Keller; Hinrich A Wieder; Tobias Dechow
Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(5):690-6.
2011: Andreas K Buck; Ken Herrmann; Florian Eckel; Ambros J Beer
Pancreatic and hepatobiliary cancers.
Methods in molecular biology (Clifton, N.J.) 2011;727():243-64.
2011: Hinrich A Wieder; Bernd J Krause; Ken Herrmann
PET and PET-CT in esophageal and gastric cancer.
Methods in molecular biology (Clifton, N.J.) 2011;727():59-76.
2010: Benjamin Balluff; Mareike Elsner; Andreas Kowarsch; Sandra Rauser; Stephan Meding; Christoph Schuhmacher; Marcus Feith; Ken Herrmann; Christoph Röcken; Roland M Schmid; Heinz Höfler; Axel Walch; Matthias P A Ebert
Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier.
Journal of proteome research 2010;9(12):6317-22.
2010: Stephan Metz; Carl Ganter; Sylvie Lorenzen; Sandra van Marwick; Ken Herrmann; Florian Lordick; Stephan Nekolla; Ernst J Rummeny; Hans-Jürgen Wester; Gunnar Brix; Markus Schwaiger; Ambros J Beer
Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolism.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(11):1691-8.
2010: Bernd J Krause; Michael Souvatzoglou; Ken Herrmann; Axel W Weber; Tibor Schuster; Andreas K Buck; Roman Nawroth; Gregor Weirich; Uwe Treiber; Hans-Jürgen Wester; Sibylle I Ziegler; Reingard Senekowitsch-Schmidtke; Markus Schwaiger
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.
European journal of nuclear medicine and molecular imaging 2010;37(10):1861-8.
2010: Thomas Wendler; Ken Herrmann; Andreas Schnelzer; Tobias Lasser; Joerg Traub; Olivier Kutter; Alexandra Ehlerding; Klemens Scheidhauer; Tibor Schuster; Marion Kiechle; Markus Schwaiger; Nassir Navab; Sibylle I Ziegler; Andreas K Buck
First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECT.
European journal of nuclear medicine and molecular imaging 2010;37(8):1452-61.
2009: Florian Eckel; Ken Herrmann; Stefan Schmidt; Claudia Hillerer; Hinrich A Wieder; Bernd J Krause; Tibor Schuster; Rupert Langer; Hans-Jürgen Wester; Roland M Schmid; Markus Schwaiger; Andreas K Buck
Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(9):1441-7.
2009: Bernd J Krause; Ken Herrmann; Hinrich A Wieder; Christian Meyer zum Büschenfelde
18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50 Suppl 1():89S-96S.
2009: Ken Herrmann; Bernd J Krause; Ralph A Bundschuh; Tobias Dechow; Markus Schwaiger
Monitoring response to therapeutic interventions in patients with cancer.
Seminars in nuclear medicine 2009;39(3):210-32.
2009: Ken Herrmann; Axel Walch; Benjamin Balluff; Marc Tänzer; Heinz Höfler; Bernd J Krause; Markus Schwaiger; Helmut Friess; Roland M Schmid; Matthias P A Ebert
Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers.
Nature clinical practice. Gastroenterology & hepatology 2009;6(3):170-83.
2008: Nicolas Graf; Ken Herrmann; Jürgen den Hollander; Falko Fend; Tibor Schuster; Hans-Jürgen Wester; Reingard Senekowitsch-Schmidtke; Christian Meyer zum Büschenfelde; Christian Peschel; Markus Schwaiger; Tobias Dechow; Andreas K Buck
Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2008;10(6):349-55.
2008: Ken Herrmann; Florian Eckel; Stefan Schmidt; Klemens Scheidhauer; Bernd J Krause; Joerg Kleeff; Tibor Schuster; Hans-Jürgen Wester; Helmut Friess; Roland M Schmid; Markus Schwaiger; Andreas K Buck
In vivo characterization of proliferation for discriminating cancer from pancreatic pseudotumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1437-44.
2008: Murat Tuncel; Michael Souvatzoglou; Ken Herrmann; Jens Stollfuss; Tibor Schuster; Gregor Weirich; Hans-Jürgen Wester; Markus Schwaiger; Bernd J Krause
[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
Nuclear medicine and biology 2008;35(6):689-95.
2008: Andreas K Buck; Stephan Nekolla; Sibylle Ziegler; Ambros J Beer; Bernd J Krause; Ken Herrmann; Klemens Scheidhauer; Hans-Jürgen Wester; Ernst J Rummeny; Markus Schwaiger; Alexander Drzezga
SPECT/CT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(8):1305-19.
2008: Andreas K Buck; Ken Herrmann; Christian Meyer Zum Büschenfelde; Malik E Juweid; Mark Bischoff; Gerhard Glatting; Gregor Weirich; Peter Möller; Hans-Jürgen Wester; Klemens Scheidhauer; Tobias Dechow; Christian Peschel; Markus Schwaiger; Sven N Reske
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(10):2970-7.
2008: Katja Ott; Ken Herrmann; Florian Lordick; Hinrich A Wieder; Wolfgang A Weber; Karen Becker; Andreas K Buck; Martin Dobritz; Ulrich Fink; Kurt Ulm; Tibor Schuster; Markus Schwaiger; Jörg Rüdiger Siewert; Bernd J Krause
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2012-8.
2008: Ambros J Beer; Sylvie Lorenzen; Stephan Metz; Ken Herrmann; Petra Watzlowik; Hans-Jürgen Wester; Christian Peschel; Florian Lordick; Markus Schwaiger
Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(1):22-9.
2008: Bernd J Krause; Michael Souvatzoglou; M Tuncel; Ken Herrmann; Andreas K Buck; C Praus; T Schuster; H Geinitz; Uwe Treiber; Markus Schwaiger
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.
European journal of nuclear medicine and molecular imaging 2008;35(1):18-23.
2007: Ken Herrmann; Katja Ott; Andreas K Buck; Florian Lordick; Dirk Wilhelm; Michael Souvatzoglou; Karen Becker; Tibor Schuster; Hans-Jürgen Wester; Jörg R Siewert; Markus Schwaiger; Bernd J Krause
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(12):1945-50.
2007: Hinrich A Wieder; Katja Ott; Florian Lordick; Karen Becker; Alexander Stahl; Ken Herrmann; Ulrich Fink; Jörg Rüdiger Siewert; Markus Schwaiger; Wolfgang A Weber
Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.
European journal of nuclear medicine and molecular imaging 2007;34(12):1925-32.
2007: Ken Herrmann; Hinrich A Wieder; Andreas K Buck; Marion Schöffel; Bernd J Krause; Falko Fend; Tibor Schuster; Christian Meyer zum Büschenfelde; Hans-Jürgen Wester; Justus Duyster; Christian Peschel; Markus Schwaiger; Tobias Dechow
Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3552-8.
2007: Hinrich A Wieder; Ken Herrmann; Katja Ott; B J Krause
[18F-FDG-PET in therapy response of esophageal cancer].
Der Radiologe 2007;47(2):110-4.
2007: Sylvie Lorenzen; Ken Herrmann; Wolfgang A Weber; Hinrich A Wieder; M Hennig; Katja Ott; Rainer Bredenkamp; Christian Peschel; Markus Schwaiger; Florian Lordick
Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.
Nuklearmedizin. Nuclear medicine 2007;46(6):263-70.